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Summary
We measured the prevalence of international travel, the demographic and risk profile of 
international travellers and risk and preventive behaviours of travellers among HIV-negative and 
HIV-positive men who have sex with men (MSM), based in San Francisco, CA, USA, through the 
addition of questions to the local implementation of the National HIV Behavioral Surveillance 
survey in 2008. Of 270 MSM participating in the survey, slightly more than one-quarter (26.3%) 
had travelled internationally in the last year. Those with a history of international travel were more 
likely to be foreign born, of a higher socioeconomic status and HIV uninfected. Of eight HIV-
positive MSM who travelled internationally (11.3% of HIV-positive MSM), all were on 
antiretroviral therapy and only three recalled being vaccinated for hepatitis A and B. Human 
papillomavirus infection was also higher among international travellers. Travel health services 
must be improved to address special needs of this population of international travellers.
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INTRODUCTION
Within the first decade following the recognition of AIDS in a cluster of men who have sex 
with men (MSM) in Los Angeles, CA, USA, HIV appeared in virtually every region of the 
world. While the origins and routes of the spread of HIV across the globe may be debated, it 
is clear that the virus spread rapidly between populations of MSM across international 
borders. The first AIDS cases detected in North America, Europe, Australia, South America 
and Asia were MSM. The first case in Thailand was in a gay man returning from living 
overseas.1 Recent years have also witnessed a resurgence in HIV transmission among MSM 
on several continents,2 most dramatically in Asia.3,4
While international travel has been associated with sexually transmitted infections (STIs),5,6 
there are fewer epidemiological data on HIV. A case-series study of MSM recently 
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diagnosed with HIV in San Francisco, CA, USA, found that the majority (55%) had 
travelled outside the USA during the period when they potentially acquired HIV infection or 
were acutely infected.7 Moreover, nearly one in eight had primary antiretroviral (ARV) drug 
resistance. The latter finding raises concern over the spread of drug-resistant strains of HIV, 
with potentially severe consequences for countries now in the process of scaling up the 
delivery of ARVs with few options for changing patient regimens.
To our knowledge, the prevalence of international travel among HIV-negative and HIV-
positive MSM has not been measured. The aims of the current study are to record the 
prevalence of international travel in the last year among MSM, characterize the demographic 
and risk profile of internationally travelling MSM, and assess their use of preventive and 
other health services. MSM were sampled in the course of the US National HIV Behavioral 
Surveillance (NHBS) survey. Such public health data can be used to track the potential for 
international transmission of HIV and ARV drug-resistant HIV, as well as to develop 
specific international travel health programmes for HIV-positive and HIV-negative MSM.
METHODS
Data originated from MSM who participated in the NHBS survey coordinated by the US 
Centers for Disease Control and Prevention (CDC). NHBS methods have been detailed 
previously.8,9 In brief, NHBS comprises serial cross-sectional surveys of persons at high 
risk of HIV in 25 cities in the USA in order to track HIV prevalence and related risk 
behaviours over time. The current study uses the second wave of the NHBS for MSM in San 
Francisco recruited by time 2 location sampling (TLS) in 2008.
The TLS methodology is used to recruit approximated probability-based samples of hard-to-
reach populations throughout the world.10 TLS begins with the creation of a list of venues, 
days and time periods where and when the target population congregates, which serves as a 
sampling frame. In the present study, formative research enumerated all possible MSM-
identified venues (e.g. bars, dance clubs, cruising areas, bookstores, gyms, social 
organizations and street locations) in San Francisco, and the days and time periods of 
attendance. From this roster of all venue–day–time (VDT) periods, a random sample of 
VDT is drawn. At the VDT, the attendance of all potentially eligible subjects is enumerated 
by counting all individuals crossing a predetermined line or zone. Research staff intercept 
men entering the zone to determine eligibility (male, age 18 years or older and resident of 1 
of 9 San Francisco Bay Area counties). If eligible, men are invited to participate and 
informed consent is obtained. Intercepts are done consecutively without the choice of the 
recruiter until all staff are occupied. Once a staff member is available, consecutive intercepts 
and interviews resume. Identifying as gay, bisexual or MSM was not an initial eligibility 
criterion in order to avoid excluding men who may not acknowledge male–male behaviour 
at the screening stage. However, our analysis includes only men identifying as gay or 
bisexual or who had a male sexual partner in the past 12 months.
Persons agreeing to participate are interviewed face-to-face at the venue using a hand-held 
computer. In addition to the national core NHBS instrument on demographic characteristics 
and HIV-related questions, we included a question on international travel in the preceding 
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12 months. The question was added approximately mid-way through the study and only to 
the San Francisco local questionnaire. After the interview, blood specimens are collected for 
HIV testing. Analysis focuses on demographic characteristics, sexual risk behaviour (e.g. 
unprotected anal intercourse), STI history and health service use among international 
travellers compared with those of non-travellers, with additional description of HIV-infected 
international travellers. The study protocol was reviewed and approved by the Institutional 
Review Boards of the University of California, San Francisco and the CDC.
RESULTS
Of 380 eligible, consecutively intercepted men at randomly selected VDT periods during the 
study period, 270 (71.1%) participated in the survey. Of these, 71 (26.3%) reported 
international travel in the 12 months preceding the interview. The median age was 36 years 
and did not differ by travel history. Higher education level, higher annual income and being 
born outside of the USA were significantly associated with international travel (Table 1). 
Having health insurance was reported by 85.9% of international travellers.
Gay sexual orientation was reported by the vast majority (87.8%) with 10.7% being bisexual 
and 1.5% identified as heterosexuals who had sex with men. The majority (83.7%) were 
‘out’ to their physicians about their sexual orientation. A similar proportion (84.4%) had 
visited their physicians in the last 12 months. Of international travellers, 2.8% had a history 
of syphilis diagnosis; past infection was also seen with gonorrhoea in 7.0%, chlamydia in 
4.2%, herpes simplex type II virus in 5.6% and human papillomavirus (HPV) infection in 
7.0%. Except for a higher prevalence of HPV among international travellers (P = 0.04), 
none of these variables were associated with international travel. Of all travellers, 59% 
reported having unprotected anal intercourse (UAI) in the last 12 months. Fifty percent of 
travellers who tested positive for HIV, and 61% of whom tested negative, reported UAI.
Men who tested HIV-positive were significantly less likely to travel internationally 
compared with HIV-negative men (11.3% versus 27.6%, respectively). All eight HIV-
positive men were aware of their HIV serostatus, were on ARV therapy, had seen their 
physician in the past 12 months and were ‘out’ to the physician about their sexual 
orientation. One of the HIV-positive travellers was foreign born. Three of the eight recalled 
being vaccinated for hepatitis A and B; three reported hepatitis B only; two recalled neither 
vaccination.
In multivariate logistic regression analysis, HIV-negative serostatus, foreign birth, higher 
education and higher income remained significantly associated with international travel in 
the last year.
DISCUSSION
With a local addition to the CDC-coordinated NHBS instrument, we were able to gauge that 
a high proportion of MSM (1 in 4) in San Francisco had travelled internationally in the last 
year in a probability-based survey. Although HIV-negative MSM were more likely to report 
international travel, a still substantial proportion of HIV-positive MSM (1 in 8) had also 
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travelled internationally in the last year. MSM who travel internationally were also more 
likely to be of higher education level and income, and foreign born.
We also found that the vast majority of internationally travelling MSM (over four-fifths) had 
seen a physician in the last year and were ‘out’ to them with regard to their sexual 
orientation. In addition, all of the HIV-positive MSM who travelled internationally were on 
ARV therapy. This high level of health access presents opportunities to enhance travel 
medicine services with specific information to include HIV prevention, HIV care and 
broader gay men’s health issues. Surprisingly, only three of eight could recall being 
vaccinated for both hepatitis A and B. We acknowledge that recall of vaccination may be 
poor; however, clinical interactions (e.g. with providers or travel clinics) will be faced with 
verifying immune status and/or revaccinating many persons. The low level of response, with 
the added uncertainties of recall, underscores the need for health education and vaccine 
promotion for MSM. This may be particularly the case for HIV-negative MSM who may 
have fewer interactions with health-care providers than HIV-positive MSM. Missed hepatitis 
B vaccination is particularly poignant given that many MSM in San Francisco participated 
in the clinical trials to prove the safety and efficacy of the vaccines.11 The original 
guidelines would have doubly prioritized this very population for vaccination: gay men and 
persons who travel internationally. With the switch to infant and childhood hepatitis 
vaccination after the 1990s, universal vaccination of our target population has not been 
achieved. Strengthening physician awareness and dissemination of the need for hepatitis A 
and B vaccination in the gay community are needed to close the gap. Additionally, the 
finding of increased HPV among internationally travelling MSM points to the potential 
benefit of vaccination for this infection.
The limitations of time within the current survey did not permit detailed measures of risk 
behaviours and ARV adherence while travelling internationally, nor did resources permit 
testing for ARV drug resistance. Future studies are needed to provide more information on 
how to create, deliver and evaluate primary and secondary HIV prevention interventions for 
those who travel across borders.
The availability of effective treatment for HIV has extended the life and wellbeing of 
persons living with infection. For many, wellbeing includes international travel for work, to 
visit family, for enjoyment and to fulfil lifetime goals. However, our estimates raise 
potential concerns for a world in which ARV therapy is rapidly being scaled up. Long-term 
treatment of HIV gives rise to increasing levels of ARV drug resistance. Americans are 
fortunate in having many options to manage their HIV infection. However, many other 
countries struggle to initiate the first line of ARV therapy; second-line therapy remains a 
challenge deferred to the future. Addressing the travel needs of HIV-positive persons 
therefore serves those living with HIV who travel abroad as well as the wider global 
community.
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Table 1
Characteristics of MSM by history of international travel in the last year, San Francisco, CA, USA, 2008
Variable
All participants (n = 
270) n (%)
No international travel in 
the last 12 months (n = 
199) n (%)
International travel in 
the last 12 months (n = 
71) n (%) P value
Education level
 Less than high school   41 (15.2)   37 (18.6)   4 (5.6) <0.001
 High school degree   96 (35.6)   82 (41.2) 14 (19.7)
 College degree 133 (49.3)   80 (40.2) 53 (74.6)
Annual income
 <US$75,000 190 (70.4) 153 (76.9) 37 (52.1) <0.001
 ≥US$75,000   80 (29.6)   46 (23.1) 34 (47.9)
Birth
 Outside USA   45 (16.7)   27 (13.6) 18 (25.4)   0.036
 In USA 225 (83.3) 172 (86.4) 53 (74.6)
Has health insurance
 Yes 211 (78.1) 150 (75.4) 61 (85.9)   0.093
 No   59 (21.9)   49 (24.6) 10 (14.1)
Race/ethnicity
 Black   20 (7.4)   18 (9.0)   2 (2.8)   0.280
 White 146 (54.1) 112 (56.3) 34 (47.9)
 Latino   66 (24.4)   45 (22.6) 21 (29.6)
 Asian   16 (5.9)   10 (5.0)   6 (8.5)
 Other   22 (8.2)   14 (7.0) 80 (11.3)
Sexual orientation
 Heterosexual     4 (1.5)     3 (1.4)   1 (1.5)   0.660
 Gay 237 (87.8) 179 (90.1) 62 (86.9)
 Bisexual   29 (10.7)   17 (8.5)   8 (11.6)
‘Out’ to physician about sexual 
orientation
 Yes 226 (83.7) 167 (83.9) 59 (83.1)   0.979
 No   44 (16.3)   32 (16.1) 12 (16.9)
Visited physician in last 12 months
 Yes 228 (84.4) 170 (85.4) 58 (81.7)   0.579
 No   42 (15.6)   29 (14.6) 13 (18.3)
Self-reported HIV status
 Negative 205 (75.9) 142 (71.4) 63 (88.7)   0.008
 Positive   63 (23.3)   55 (27.6)   8 (11.3)
Numbers do not always add up to 100% due to missing data. MSM = men who have sex with men
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